Search results for "Outbreak"

showing 10 items of 812 documents

Is elimination of HCV in 2030 realistic in Central Europe.

2021

According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV e…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Hepatitis C virusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.disease_causeAntiviral Agents03 medical and health sciences0302 clinical medicineEpidemiologymedicinePrevalenceHumansHepatologybusiness.industrySARS-CoV-2virus diseasesCOVID-19Hepatitis Cmedicine.diseaseVirologyHepatitis Cdigestive system diseasesHcv eliminationEuropeRegimen030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessLiver international : official journal of the International Association for the Study of the LiverREFERENCES
researchProduct

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

2021

ABSTRACTEndothelial injury and microvascular/macrovascular thrombosis are common pathophysiologic features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and critically-ill patients with COVID-19. This manuscript provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterpri…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Hospitalized patientsbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)law.inventionClinical trialRandomized controlled triallawAntithromboticmedicineIllness severityIntensive care medicinebusiness
researchProduct

Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Inclusion (disability rights)Pneumonia ViralMEDLINEArticlelaw.inventionBetacoronavirusRandomized controlled triallawHumansMedicinePregnancy Complications InfectiousIntensive care medicinePandemicsClinical Trials as TopicPregnancySARS-CoV-2business.industryPatient SelectionCOVID-19clinical trialmedicine.diseasedrug developmentClinical trialAnesthesiology and Pain MedicineDrug developmentFemalepregnancyCoronavirus Infectionsbusinessrandomised controlled trialBritish Journal of Anaesthesia
researchProduct

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEBetacoronavirusRisk FactorsInternal medicinePandemicAtrial FibrillationmedicineHumansRisk factorPandemicsbiologybusiness.industrySARS-CoV-2Discussion ForumCOVID-19Atrial fibrillationmedicine.diseasebiology.organism_classificationPrognosisItalyCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsCoronavirus InfectionsBetacoronavirusEuropean heart journal
researchProduct

COVID-19 in thrombosis research: An editorial perspective

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)10031 Clinic for AngiologyPerspective (graphical)2720 HematologyMEDLINECOVID-19Thrombosis610 Medicine & healthHematologyThrombosis ResearchEditorialHumansMedicinebusinessIntensive care medicine
researchProduct

Immunologic characterization of COVID-19 patients with hematological cancer

2020

Not available.

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19CancerCOVID-19Hematologic Neoplasms Humans SARS-CoV-2HematologyHematologic Neoplasmsmedicine.diseaseVirologyHematologic NeoplasmsEpidemiologymedicineHumansLetters to the Editorbusiness
researchProduct

COVID-19 lockdown influence in the psychiatric emergencies: Drastic reduction and increase in severe mental disorders.

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe Mental DisordersSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical DistancingMEDLINESeverity of Illness IndexRisk FactorsPsychiatric emergenciesMedicineHumansRegistriesEmergency Services Psychiatricbusiness.industryHealth PolicyMental DisordersCOVID-19General MedicinePatient Acceptance of Health CarePsychiatry and Mental healthSpainEmergency medicineQuarantineEmergenciesbusinessScientific LetterFacilities and Services UtilizationRevista de psiquiatria y salud mental
researchProduct

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEGlobal HealthArticleBetacoronavirusInternal medicinePandemicGlobal healthMedicineHumansMortalityBlood CoagulationPandemicsbiologybusiness.industrySARS-CoV-2AnticoagulantsCOVID-19Thrombosismedicine.diseasebiology.organism_classificationVirologySurvival RatePneumoniaMeta-analysisCardiologyCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsBetacoronavirusThe American journal of cardiology
researchProduct

The Impact of School Closure on Adolescents’ Wellbeing, and Steps toward to a New Normal : The Need for an Assessment Tool Update?

2021

International audience; Close to 200 countries have implemented school closures to decrease the spread of the COVID-19 coronavirus. Though the closures have seemed necessary, their effects on the wellbeing of children and adolescents have raised serious concerns. To truly understand the impact of such disruption on young people’s wellbeing, and their views on how to move towards a new normal, we must adopt different approaches to gather the data to secure children’s and adolescents’ rights to be heard in the issues that concern their lives. Current ways to examine the impacts of school closure have been dominated by gathering information concerning the children and adolescents, using mainly…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SHS.EDU]Humanities and Social Sciences/EducationassessmenthyvinvointiRC435-571PediatricsRJ1-570Developmental psychologywellbeingnuoretetäopetusmedicinePsychologyadolescentsPsychiatrykoulutsulkeminenPublic healthCOVID-19General Medicineschool closureBF1-990New normalpoikkeusolot[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePsychology
researchProduct

Therapeutic advances from the 16th Baltic Association of Dermatovenereologists Congress, University of Latvia, Riga, Latvia Hybrid Conference: Zoom t…

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryFamily medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicineDermatologyGeneral MedicinebusinessDermatologic Therapy
researchProduct